Top Markets
#1 SAFEcoin SAFEcoin +41.13%
#2 Zora Zora +40.50%
#3 AI XOVIA AI XOVIA +23.13%
#4 Full Moon Full Moon +18.75%
#5 Merlin's Seal BTC Merlin's Seal BTC +16.53%
#6 0G 0G +16.00%
#7 Cysic Cysic +14.97%
#8 Apertum Apertum +14.94%
#9 Axelar Axelar +14.62%
#10 VVS Finance VVS Finance +13.45%
Coin of the day
SAFEcoin SAFEcoin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
Rang in aandelen #12604
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Aandeelprijs
$9.09
Laatst gesynchroniseerd: 2023-06-23
Marktkapitalisatie
$567.77M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel CTI BioPharma Corp. (CTIC)

Categorie

Healthcare
P/B-ratio voor CTI BioPharma Corp. (CTIC)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van CTI BioPharma Corp. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor CTI BioPharma Corp. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH